1. Characteristics of patients with lung cancer in clinical practice and their potential eligibility for clinical trials evaluating tyrosine kinase inhibitors or immune checkpoint inhibitors. (June 2022) Authors: van Veelen, Ard; Abtahi, Shahab; Souverein, Patrick; Driessen, Johanna H.M.; Klungel, Olaf H.; Dingemans, Anne-Marie C.; van Geel, Robin; de Vries, Frank; Croes, Sander Journal: Cancer epidemiology Issue: Volume 78(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Development and validation of an HPLC–MS/MS method to simultaneously quantify alectinib, crizotinib, erlotinib, gefitinib and osimertinib in human plasma samples, using one assay run. (31st August 2021) Authors: van Veelen, Ard; van Geel, Robin; Schoufs, Roy; de Beer, Yvo; Stolk, Leo M.; Hendriks, Lizza E. L.; Croes, Sander Journal: Biomedical chromatography Issue: Volume 35:Number 12(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pharmacokinetic boosting of osimertinib with cobicistat in patients with non-small cell lung cancer: The OSIBOOST trial. (September 2022) Authors: van Veelen, Ard; Gulikers, Judith; Hendriks, Lizza E.L.; Dursun, Safiye; Ippel, Juanita; Smit, Egbert F.; Dingemans, Anne-Marie C.; van Geel, Robin; Croes, Sander Journal: Lung cancer Issue: Volume 171(2022) Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Phase I Study of Afatinib and Selumetinib in Patients with KRAS‐Mutated Colorectal, Non‐Small Cell Lung, and Pancreatic Cancer. (29th December 2020) Authors: van Brummelen, Emilie M.J.; Huijberts, Sanne; van Herpen, Carla; Desar, Ingrid; Opdam, Frans; van Geel, Robin; Marchetti, Serena; Steeghs, Neeltje; Monkhorst, Kim; Thijssen, Bas; Rosing, Hilde; Huitema, Alwin; Beijnen, Jos; Bernards, Rene; Schellens, Jan Journal: Oncologist Issue: Volume 26:Number 4(2021) Page Start: 290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Validation of an analytical method using HPLC–MS/MS to quantify osimertinib in human plasma and supplementary stability results. (3rd February 2020) Authors: van Veelen, Ard; van Geel, Robin; de Beer, Yvo; Dingemans, Anne‐Marie; Stolk, Leo; ter Heine, Rob; de Vries, Frank; Croes, Sander Journal: Biomedical chromatography Issue: Volume 34:Number 4(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗